Encora Therapeutics’ Abstract at 2025 American Academy of Neurology (AAN) Annual Meeting Selected for Merit as “Abstract of Distinction”

SAN DIEGO–(BUSINESS WIRE)–Encora Therapeutics today announced that its abstract, Safety and Efficacy of a Wrist-worn Vibratory Stimulation Wearable for Upper Limb Tremor Reduction in Essential Tremor (ULTRE): A Randomized, Controlled Trial, was honored as an “Abstract of Distinction” by the American Academy of Neurology (AAN) and the Science Committee at the recent AAN 2025 Annual Meeting. This distinction was awarded to the single top-rated abstract out of over 300 in its topic category of Movement Disorders “based on the quality of study and interest to the neurologic community”.